2027 open enrollment. 3.15 million people must pick a new Medicare Advantage plan. See every plan and county, free.3.15M must pick a new plan.
Look up your countyYour county →Drugs Data World
| Source | The data | Years |
|---|---|---|
| What a drug costs | ||
| Pharmacy acquisition cost | NADAC, weekly, by NDC. | 2013 to 2026 |
| Medicare Part B | ASP prices quarterly with the NDC-to-HCPCS crosswalk; Part B spending by drug; discarded units. | 2005 to 2026 |
| Part D plans | Every plan's drug prices, formulary, tiers and restrictions, quarterly. | 2019 to 2026 |
| Other channels | VA federal supply schedule prices; Cost Plus cash prices; California's reported list-price increases. | 2019 to 2026 |
| Negotiated prices | The maximum fair prices from the Medicare negotiation program. | 2026 to 2027 |
| What the FDA says | ||
| Identity and approval | The NDC directory, Drugs@FDA applications, the Orange and Purple Books, master files, device identifiers. | 2016 to 2026 |
| Labels and classes | Structured product labels; NLM drug classes. | 2024 to 2026 |
| Safety | Recalls, shortages, adverse events, warning letters, controlled-substance schedules. | 2012 to 2026 |
| Trials | FDA-regulated drug trials from ClinicalTrials.gov. | 2026 |
| Who is paid | ||
| Industry payments | Open Payments to physicians and hospitals. | 2016 to 2025 |
| Who prescribes | Part D claims by prescriber and drug. | 2013 to 2024 |
| What is not here | ||
| Rebates and net prices are not public. Retail cash prices are held for one channel only. | ||
Built from 19 CMS release streams. Every table, its columns and its dates